Request a Demo and Enjoy a Free Trial→
ArchiWise
Eli Lilly Begins $3.5B Lehigh Valley Manufacturing Plant in Upper Macungie

Eli Lilly Begins $3.5B Lehigh Valley Manufacturing Plant in Upper Macungie

Infrastructure

Eli Lilly has started construction on a $3.5 billion manufacturing campus in Upper Macungie, a Lehigh Valley community in Pennsylvania. The complex will span roughly 925,000 square feet spread across several buildings and will support production of injectable medicines and other medical devices.

The company is projected to add about 850 permanent jobs in the region, while the build-out is expected to support around 2,000 construction positions. Lilly bought the property at 9802 Main St., known as the Fogelsville Corporate Center, from Jaindl Land Development earlier this year, according to local reporting.

The project was announced earlier in the year with state backing. Pennsylvania Governor Josh Shapiro said the state committed more than $100 million in incentives, including $50 million in tax credits. Lehigh Carbon Community College is also set to receive state funding to expand life sciences training programs that will feed Lilly's hiring pipeline.

For developers and lenders, the deal signals sustained demand for large-format pharmaceutical manufacturing space in the Lehigh Valley, with incentive-backed projects likely to shape local industrial and workforce planning.

Topics

eli-lillyfogelsville-corporate-centerjaindl-land-developmentlehigh-carbon-community-collegelehigh-valleyupper-macungie

More in Pennsylvania